In vitro dissolution kinetics of captopril from microspheres manufactured by Solvent Evaporation

Dissolution Technologies

Volumn 19, Issue 1, 2012, Pages 42-51

  Khamanga, Sandile M ^a   Walker, Roderick B ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; EUDRAGIT RS; METHYLCELLULOSE; MICROSPHERE; SOLVENT;

ARTICLE; DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; EVAPORATION; KINETICS;

EID: 84857936660     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT190112P42     Document Type: Article

References (41)

1. Gianotto, E. A.; Arantes, R. P.; Lara-Filho, M. J.; Filho, A. C. S. C.; Fregonezi-Nery, M. M. Dissolution test for glibenclamide tablets. Quím. Nova 2007, 30 (5), 1218-1221.
2. Costa, P.; Sousa Lobo, J. M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13 (2), 123-133.
3. Hanson, R.; Gray, V. Handbook of Dissolution Testing, 3rd ed.; Dissolution Technologies, Inc.: Hockessin, DE, 2004.
4. Kanfer, I. Workshop Report-Challenges in Dissolution Testing: Equivalence and Surrogates. Dissolution Technol. 2010, 17 (3), 41-50.
5. Underwood, T.; Cadwalladaer, D. Automated potentiometric procedure for studying dissolution kinetics of acidic drugs under sink conditions. J. Pharm. Sci. 1978, 67 (8), 1163-1167.
6. Chiou, W. I.; Riegelman, S. Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. J. Pharm. Sci. 1970, 59 (7), 937-941.
7. García, C. V.; Paim, C. S.; Steppe, M.; Schapoval, E. E. S. Development and validation of a dissolution test for rabeprazole sodium in coated tablets. J. Pharm. Biomed. Anal. 2006, 41 (3), 833-837.
8. Reddy, K. R.; Mutalik, S.; Reddy S. Once-Daily Sustained-Release Matrix Tablets of Nicorandil: Formulation and In Vitro Evaluation. AAPS PharmSciTech 2003, 4 (4), 480-488. http://www.springerlink.com/content/7104416110g33lp7/fulltext.pdf (accessed Jan 15, 2012).
9. Kim, H.; Fassihi, R. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs. I. Diltiazem hydrochloride. Pharm. Res. 1997, 14 (10), 1415-1421.
10. Williams, T. A.; Corvol, P.; Soubrier, F. Identification of Two Active Site Residues in Human Angiotensin I-converting Enzyme. J. Biol. Chem. 1994, 269 (47), 29430-29434.
11. Williams, T. A.; Michaud, A.; Houard, X.; Chauvet, M.-T.; Soubrier, F.; Corvol, P. Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity. Biochem. J. 1996, 318, 125-131.
12. Ooi, H.; Colucci, W. Pharmacological Treatment of Heart Failure. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed.; Hardman, J. G., Limbird, L. E., Eds.; McGraw Hill: New York, 2001; p 910.
13. Ondetti, M. A.; Cushman, R. B. D. W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 1977, 196 (4288), 441-444.
14. Wilding, I. R.; Davis, S. S.; Bakhshaee, M.; Stevens, H. N. E; Sparrow, R. A.; Brennan, J. Gastrointestinal transit and systemic absorption of captopril from a pulsedrelease formulation. Pharm. Res. 1992, 9 (5), 654-657.
15. Aboul-Enein, H. Y.; Al-Badr, A. A.; Ibrahim, S. E. Salbutamol. In Analytical Profiles of Drug Substances; Flory, K., Ed.; Academic Press, Inc.: New York, 1981; Vol. 10, p 665.
16. Worland, P. J.; Drummer, O. H.; Jarrott, B. Gastric and intestinal absorption of captopril in acutely and chronically treated rats: Comparison with salicylic acid. J. Pharm. Sci. 1984, 73 (12), 1755-1758.
17. Macêdo, R. O.; Gomes do Nascimento, T.; Soares Aragão, C. F.; Barreto Gomes, A. P. Application of Thermal Analysis in the Characterization of Anti-hypertensive Drugs. J. Therm. Anal. Calorim. 2000, 59 (3), 657-661.
18. Sweetman, S. C., Ed. Martindale, the Complete Drug Reference, 35th ed.; Pharmaceutical Press: London, 2007; pp 1112-1113.
19. Khamanga, S. M.; Parfitt, N.; Nyamuzhiwa, T.; Haidula, H.; Walker, R. B. The Evaluation of Eudragit Microcapsules Manufactured by Solvent Evaporation Using USP Apparatus 1. Dissolution Technol. 2009, 16 (2), 15-22.
20. Khamanga, S. M.; Walker, R. B. The use of experimental design in the development of an HPLC-ECD method for the analysis of captopril. Talanta 2011, 183 (3), 1037-1049.
21. Kumar, P.; Singh, S.; Mishra, B. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology. Acta Pharmaceut. 2009, 59 (1), 15-30.
22. Sonnergaard, J. M. On the misinterpretation of the correlation coefficient in pharmaceutical sciences. Int. J. Pharm. 2006,321 (1-2), 12-17.
23. Hunter, J. S. Calibration and the straight line: current statistical practices. J. Assoc. Off. Anal. Chem. 1981, 64, 574-583.
24. Badino, A. C. Jr.; Facciotti, M. C. R.; Schmidell, W. Volumetric oxygen transfer coefficients (kLa) in batch cultivations involving non-Newtonian broths. Biochem. Eng. J. 2001, 8, 111-119.
25. Corbett, B. M. Selecting a best-fit temperaturedependent regression model for thin target HVI data. Int. J. Impact Eng. 2008, 35 (12), 1672-1677.
26. Donbrow, M.; Samuelov, Y. Zero order drug delivery from double-layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures. J. Pharm. Pharmacol. 1980, 32 (7), 463-470.
27. Varelas, C. G.; Dixon, D. G.; Steiner, C. A. Zero-order release from biphasic polymer hydrogels. J. Control. Release. 1995, 34 (3), 185-192.
28. Gibaldi, M.; Feldman, S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J. Pharm. Sci. 1967, 56 (10), 1238-1242.
29. Wagner, J. G. Interpretation of percent dissolved time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 1969, 58 (10), 1253-1257.
30. Higuchi, T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50 (10), 874-875.
31. Higuchi, T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52 (12), 1145-1149.
32. Pais, J. Intuiting Mathematical Objects Using Diagrams and Kinetigrams. JOMA 2001, 1 (2). http://mathdl.maa.org/mathDL/4/?pa=content&sa=viewDocument&nodeId=429 (accessed Jan 12, 2012).
33. Kopcha, M.; Lordi, N. G.; Tojo, K. J. Evaluation of release from selected thermosoftening vehicles. J. Pharm. Pharmacol. 1991, 43 (3), 382-387.
34. Korsmeyer, R. W.; Peppas, N. A. Macromolecular and modeling aspects of swelling-controlled systems. In Controlled Release Delivery Systems; Roseman, T. J., Mansdorf, S. Z., Eds.; Marcel Dekker, Inc.: New York, 1981.
35. Korsmeyer, R. W.; Gurny, R.; Doelker, E. M.; Buri, P.; Peppas, N. A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15 (1), 25-35.
36. Peppas, N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta. Helv. 1985, 60 (4), 110-111.
37. Khamanga, S. M. M.; Walker, R. B. The Effects of Buffer Molarity, Agitation Rate, and Mesh Size on Verapamil Release from Modified-Release Mini-Tablets Using USP Apparatus 3. Dissolution Technol. 2007, 14 (2), 19-23.
38. Ubrich, N.; Bouillot, P.; Pellerin, C.; Hoffman, M.; Maincent, P. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study. J. Control. Release 2004, 97 (2), 291-300.
39. Pygall, S. R.; Kujawinski, S.; Timmins, P.; Melia, C. D. Mechanisms of drug release in citrate buffered HPMC matrices. Int. J. Pharm. 2009, 370 (1-2), 110-120.
40. Bravo, S. A.; Lamas, M. C.; Salomon C. J. Swellable matrices for the controlled-release of diclofenac sodium: Formulation and in vitro studies. Pharm. Dev. Technol. 2004, 9 (1), 75-83.
41. Ebube, N. K.; Jones, A. B. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers. Int. J. Pharm. 2004, 272 (1-2), 19-27.